Depatuxizumab mafodotin [1585973-65-4]

MedChem Express

Depatuxizumab mafodotin [1585973-65-4]

5

1585973-65-4

Research Use Only

99.73

Depatuxizumab mafodotin (ABT-414) is an antibody-drug conjugate (ADC). Depatuxizumab mafodotin specifically targets the epidermal growth factor receptor (EGFR). Depatuxizumab mafodotin can be used in the study of glioma, head and neck squamous cell carcinoma, non-small cell lung cancer, epidermoid carcinoma of the skin, and squamous cell carcinoma of the tongue[1][2][3][4][5].

-80°C

41116161